CVS Health Drops as Medical Cost Trends Prompt Guidance Cut
Centene Is Maintained at Hold by Deutsche Bank
Centene Is Maintained at Hold by Deutsche Bank
Deutsche Bank: Maintaining the Centene (CNC.US) rating, adjusted from holding to holding rating, and adjusted the target price from $81.00 to $82.00.
Deutsche Bank: Maintaining the Centene (CNC.US) rating, adjusted from holding to holding rating, and adjusted the target price from $81.00 to $82.00.
Deutsche Bank Maintains Hold on Centene, Raises Price Target to $82
Deutsche Bank analyst George Hill maintains Centene (NYSE:CNC) with a Hold and raises the price target from $81 to $82.
Jefferies Adjusts Price Target on Centene to $90 From $94
Centene (CNC) has an average rating of outperform and price targets ranging from $73.30 to $110, according to analysts polled by Capital IQ.
Centene Is Maintained at Outperform by Oppenheimer
Centene Is Maintained at Outperform by Oppenheimer
Oppenheimer: Maintaining the Centene (CNC.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $110.00 to $110.00.
Oppenheimer: Maintaining the Centene (CNC.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $110.00 to $110.00.
Oppenheimer Maintains Outperform on Centene, Maintains $110 Price Target
Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and maintains $110 price target.
Centene Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 48.65% Oppenheimer $110 → $110 Maintains Outperform 04/15/2024 25.68% Wells Fargo $89 → $93 Mai
Oppenheimer Sticks to Its Buy Rating for Centene (CNC)
Truist Financial Remains a Buy on Centene (CNC)
Centene's Resilience Amid Medicaid Pressures Justifies Buy Rating and $93 Price Target
Returns On Capital At Centene (NYSE:CNC) Have Hit The Brakes
Centene Corp (CNC) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Insights
Decoding Centene Corp (CNC): A Strategic SWOT Insight
Goldman Sachs Sticks to Its Hold Rating for Centene (CNC)
Earnings Call Summary | Centene(CNC.US) Q1 2024 Earnings Conference
The following is a summary of the Centene Corporation (CNC) Q1 2024 Earnings Call Transcript:Financial Performance:Centene reported a Q1 adjusted EPS of $2.26, exceeding expectations and raised its fu
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Centene Corporation
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $80
Centene's First-Quarter Surge: Sales Soar To $40.41B, Exceeding Expectations: What's Next For The Healthcare Company?
Centene Corporation (NYSE:CNC) reported first-quarter sales of $40.41 billion, up 11% Y/Y, beating the consensus of $36.14 billion.Premium and service revenues increased 4% to $36.3 billion, driven by
Sector Update: Health Care Stocks Mixed Premarket Friday
Health care stocks were mixed premarket Friday as the Health Care Select Sector SPDR Fund (XLV) was down 0.3% and the iShares Biotechnology ETF (IBB) was recently up 0.2% Centene (CNC) was up 0.4% aft
No Data